| Autor: |
Moya‐Martinez, C., Berná‐Rico, E.D., Melian‐Olivera, A., Moreno‐Garcia del Real, C., Fernández‐Nieto, D. |
| Předmět: |
|
| Zdroj: |
Journal of the European Academy of Dermatology & Venereology; Feb2022, Vol. 36 Issue 2, pe95-e97, 3p |
| Abstrakt: |
Several aetiological agents have been suggested, such as insect bites, ECHO virus, cytomegalovirus, adenovirus and EBV, among others.4 Recently, Alonzo Caldarelli I et al i . suggested EP as a paraviral manifestation of COVID-19 infection.3 Paraviral eruptions can be distinguished from typical virus eruptions because they have a characteristic clinical presentation, last longer, can be triggered by many different viruses, and there is no specific cytopathogenic effect on microscopic examination. (b) Papules coalesced on the vaccination arm on an erythematous plaque reminding "COVID-arm" vaccine reaction. gl EP was first described by Cherry JD I et al i .2 in four children with acute enteroviruses-enteric cytopathic human orphan (ECHO) virus infection. Comment on 'Development of eruptive pseudoangiomatosis following COVID-19 inmunization-apropos of 5 cases': could eruptive pseudoangiomatosis represent a paraviral eruption associated with SARS-CoV-2?. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text